Infection, immunoregulation, and cancer

作者: Graham A. W. Rook , Angus Dalgleish

DOI: 10.1111/J.1600-065X.2010.00987.X

关键词: InflammationTumor necrosis factor alphaInflammatory bowel diseaseAutoimmunityImmunologyHygiene hypothesisInterleukin 10MedicineCancerCarcinogenesisImmunology and Allergy

摘要: As man has moved rapidly from the hunter-gatherer environment to living conditions of industrialized countries, incidences some cancers have increased alarmingly. Recent increases are usually attributed dietary changes or altered exposures putative carcinogens associated with modern lifestyle. However, in cancer incidence parallel similar non-neoplastic chronic inflammatory disorders (inflammatory bowel disease, allergies, and autoimmunity), epidemiology is often strikingly similar. This worth exploring, because at least partly explained by immunoregulatory defects resulting diminished exposure microorganisms that co-evolved mammals developed a role driving circuits (the hygiene hypothesis). Dysregulated inflammation can drive oncogenesis also provides growth angiogenic factors enhance subsequent proliferation spread tumor cells. Thus, failure downregulate inappropriate could underlie disorders. possibility supported recent work showing circumstances regulatory T cells protect against cancer, rather than aggravating it, as previously assumed. A greater understanding these interactions might pave way improved microbe-based immunotherapies.

参考文章(160)
Graham A. W. Rook, Christopher A. Lowry, The hygiene hypothesis and affective and anxiety disorders In: Rook, GAW, (ed.) The Hygiene Hypothesis and Darwinian Medicine. Birkhauser (2009). pp. 189- 220 ,(2009) , 10.1007/978-3-7643-8903-1_11
James. G. Fox, Timothy C. Wang, Reply to "The 'African enigma' - another explanation" Nature Medicine. ,vol. 6, pp. 1297- 1298 ,(2000) , 10.1038/82066
K. F. Kölmel, A. Pfahlberg, G. Mastrangelo, M. Niin, I. N. Botev, C. Seebacher, D. Schneider, D. Lambert, R. Shafir, E. M. Kokoschka, U. R. Kleeberg, B. M. Henz, O. Gefeller, Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer. Melanoma Research. ,vol. 9, pp. 511- 520 ,(1999) , 10.1097/00008390-199910000-00011
Norbert Müller, COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Current opinion in investigational drugs. ,vol. 11, pp. 31- 42 ,(2010)
Thomas Doetschman, Gregory P. Boivin, Peter S. Gartside, Sandra J. Engle, Ilona Ormsby, James B. Hoying, Transforming Growth Factor β1 Suppresses Nonmetastatic Colon Cancer at an Early Stage of Tumorigenesis Cancer Research. ,vol. 59, pp. 3379- 3386 ,(1999)
Jillian R Satin, Wolfgang Linden, Melanie J Phillips, None, Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. ,vol. 115, pp. 5349- 5361 ,(2009) , 10.1002/CNCR.24561
MER O'Brien, A Saini, IE Smith, A Webb, K Gregory, R Mendes, C Ryan, K Priest, KV Bromelow, RD Palmer, N Tuckwell, DA Kennard, BE Souberbielle, None, A randomized phase II study of SRL172 ( Mycobacterium vaccae ) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma British Journal of Cancer. ,vol. 83, pp. 853- 857 ,(2000) , 10.1054/BJOC.2000.1401
Marc Lecuit, Immunoproliferative small intestinal disease associated with Campylobacter jejuni Hematology Meeting Reports (formerly Haematologica Reports). ,vol. 1, ,(2009) , 10.4081/HMR.V1I5.265
James G. Fox, Paul Beck, Charles A. Dangler, Mark T. Whary, Timothy C. Wang, Hai Ning Shi, Cathryn Nagler-Anderson, Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy Nature Medicine. ,vol. 6, pp. 536- 542 ,(2000) , 10.1038/75015
Rik Derynck, Rosemary J. Akhurst, Allan Balmain, TGF-beta signaling in tumor suppression and cancer progression. Nature Genetics. ,vol. 29, pp. 117- 129 ,(2001) , 10.1038/NG1001-117